| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |